Skip to main content

Mood Effects of Serotonin Agonists: Depression

This study will examine the effect of a low dose of the 5HT2A agonist LSD (26 µg), compared to placebo, on acute and protracted mood states in individuals with depression. The investigators will assess the relationship between mood-related symptoms and EEG as a neurophysiological marker.

Status
completed
Phase
Early Phase 1
Institution
University of Chicago
Principal investigator
Hanna Molla
Start date
2025-06-09
End date
2026-06-01
Registry ID
NCT07017478

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.